First-line treatment for locally advanced or metastatic urothelial carcinoma: a randomized controlled phase III study comparing pembrolizumab with and without platinum-based combination chemotherapy and chemotherapy alone in patients with advanced or metastatic urothelial carcinoma (Keynote-361) AB 54/16 of AUO

被引：0
|
作者：
Rexer, H. [1 ]
Ohlmann, C. -H. [2 ]
Retz, M. [3 ]
机构：
[1] AUO Geschaftsstelle, Seestr 11, D-17252 Schwarz, Germany
[2] Arbeitsgemeinschaft Urol Onkol Deutsch Krebsgesel, Organgrp Blasenkarzinom, Kuno Fischer Str 8, D-14057 Berlin, Germany
[3] Tech Univ Munich, Urol Klin & Poliklin, LKP, Klinikum Rdl, Ismaninger Str 22, D-81675 Munich, Germany
来源：
AKTUELLE UROLOGIE | 2018年 / 49卷 / 01期
关键词：
D O I：
10.1055/s-0043-125341
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：21 / 22
页数：2
相关论文
共 50 条
  • [21] Trial in progress: A phase 2, randomized, open-label study of trilaciclib with first-line, platinum-based chemotherapy and avelumab maintenance in untreated patients with locally advanced or metastatic urothelial carcinoma (PRESERVE 3).
    Sonpavde, Guru P.
    Grivas, Petros
    Milowsky, Matthew I.
    Galsky, Matt D.
    Malik, Rajesh K.
    Beelen, Andrew Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [22] Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
    Grande, Enrique
    Bamias, Aristotelis
    Galsky, Matthew D.
    Kikuchi, Eiji
    Davis, Ian D.
    Arranz, Jose Angel
    Kalebasty, Arash Rezazadeh
    del Muro, Xavier Garcia
    Park, Se Hoon
    De Giorgi, Ugo
    Alekseev, Boris
    Mencinger, Marina
    Izumi, Kouji
    Puente, Javier
    Li, Jian-Ri
    Bernhard, Sandrine
    Nicholas, Alan
    Telliez, Julie
    De Santis, Maria
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 58 : 28 - 36
  • [23] Impact of the objective response to and number of cycles of platinum-based first-line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab
    Kato, Minoru
    Kobayashi, Takashi
    Matsui, Yoshiyuki
    Ito, Katsuhiro
    Hikami, Kensuke
    Yamada, Takeshi
    Ogawa, Kosuke
    Nakamura, Kenji
    Sassa, Naoto
    Yokomizo, Akira
    Abe, Takashige
    Tsuchihashi, Kazunari
    Tatarano, Shuichi
    Inokuchi, Junichi
    Tomida, Ryotaro
    Fujiwara, Maki
    Takahashi, Atsushi
    Matsumoto, Kazumasa
    Shimizu, Kosuke
    Araki, Hiromasa
    Kurahashi, Ryoma
    Ozaki, Yu
    Tashiro, Yu
    Uegaki, Masayuki
    Kojima, Takahiro
    Uchida, Junji
    Ogawa, Osamu
    Nishiyama, Hiroyuki
    Kitamura, Hiroshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (12) : 1261 - 1267
  • [24] The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma
    Okita, Kazutaka
    Hatakeyama, Shingo
    Hagiwara, Kazuhisa
    Suzuki, Yuichiro
    Tanaka, Toshikazu
    Noro, Daisuke
    Tokui, Noriko
    Fujita, Naoki
    Konishi, Sakae
    Okamoto, Teppei
    Yoneyama, Tohru
    Yamamoto, Hayato
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Ohyama, Chikara
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (12) : 832.e17 - 832.e23
  • [25] Quantitative circulating tumor DNA (ctDNA) assessment in patients (pts) with advanced urothelial carcinoma (UC) treated with pembrolizumab (pembro) or platinum-based chemotherapy (chemo) from the phase 3 KEYNOTE-361 trial
    Powles, Thomas
    Chang, Wayne Yen-Hwa
    Yamamoto, Yoshiaki
    Munoz-Langa, Jose
    Reyes, Felipe
    Peer, Avivit
    Yu, Evan Y.
    Cohen, Graham
    Lorch, Anja
    Bavle, Abhishek
    Moreno, Blanca Homet
    Markensohn, Julia
    Edmondson, Mackenzie
    Chen, Cai
    Cristescu, Razvan
    Pena, Carol Elaine
    Lunceford, Jared
    Gunduz, Seyda
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study
    Narita, Takuma
    Hatakeyama, Shingo
    Numakura, Kazuyuki
    Kobayashi, Mizuki
    Muto, Yumina
    Saito, Mitsuru
    Narita, Shintaro
    Tanaka, Toshikazu
    Noro, Daisuke
    Tokui, Noriko
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Habuchi, Tomonori
    Ohyama, Chikara
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (09) : 899 - 905
  • [27] First-line Treatment of untreated, non-resectable or metastatic Urothelial Carcinoma: An open, randomized, Phase III Study of Nivolumab in Combination with Ipilimumab or Standard Chemotherapy versus Standard-Chemotherapy in Patients with previously untreated inoperable or metastatic Urothelial Carcinoma (CheckMate-901) - AB 59/17 of the AUO
    Rexer, H.
    Retz, M.
    Waller, C.
    AKTUELLE UROLOGIE, 2019, 50 (01) : 20 - 21
  • [28] Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy
    N. Houédé
    G. Locker
    C. Lucas
    H. Soto Parra
    U. Basso
    D. Spaeth
    R. Tambaro
    L. Basterretxea
    F. Morelli
    C. Theodore
    L. Lusuardi
    N. Lainez
    A. Guillot
    G. Tonini
    J. Bielle
    X. Garcia Del Muro
    BMC Cancer, 16
  • [29] Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy
    Houede, N.
    Locker, G.
    Lucas, C.
    Parra, H. Soto
    Basso, U.
    Spaeth, D.
    Tambaro, R.
    Basterretxea, L.
    Morelli, F.
    Theodore, C.
    Lusuardi, L.
    Lainez, N.
    Guillot, A.
    Tonini, G.
    Bielle, J.
    Del Muro, X. Garcia
    BMC CANCER, 2016, 16
  • [30] Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy
    Bellmunt, Joaquim
    Zhou, Chensheng Willa
    Mullane, Stephanie A.
    Werner, Lillian
    Taplin, Mary-Ellen
    Fay, Andre P.
    Choueiri, Toni K.
    Orsola, Anna
    Takeda, David Y.
    Hahn, William C.
    Kim, Jaegil
    Sonpavde, Guru
    Bowden, Michaela
    BRITISH JOURNAL OF CANCER, 2016, 115 (01) : 12 - 19
12345